Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1983;5:584-590

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trimarco, B.
Right arrow Articles by Condorelli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trimarco, B.
Right arrow Articles by Condorelli, M.

Hypertension, Vol 5, 584-590, Copyright © 1983 by American Heart Association


ARTICLES

Studies of the mechanisms underlying impairment of beta-adrenoceptor- mediated effects in human hypertension

B Trimarco, M Volpe, B Ricciardelli, GB Picotti, MD Galva, R Petracca and M Condorelli

To investigate the impairment of beta-adrenoceptor responsiveness in human hypertension, we evaluated the effect of an oral salt load (400 mEq/day of NaCl for 7 days) on plasma catecholamine concentrations and beta-adrenoceptor-mediated effects in 11 young patients with mild essential hypertension. Responses of heart rate and plasma cAMP to isoproterenol administration were used as indices of beta-adrenoceptor responsiveness. Salt loading induced a significant reduction in the dose of isoproterenol required to raise the heart rate by 25 bpm (CD25) (from 7.6 +/- 1.5 to 5.3 +/- 0.9 micrograms, p less than 0.05) and an increase in the slopes of the regression lines for heart rate changes and isoproterenol doses (delta HR/IS) (from 3.3 +/- 0.6 to 4.7 +/- 0.7, p less than 0.05) and for plasma cyclic AMP (cAMP) level changes and isoproterenol doses (delta cAMP/IS) (from 0.3 +/- 0.06 to 1.4 +/- 0.3, p less than 0.05). After salt loading there was a significant reduction in plasma catecholamine concentrations with a significant relationship between changes in upright plasma epinephrine levels and changes in CD25 (r = 0.904, p less than 0.01) and in the slopes for delta HR/IS (r = 0.983, p less than 0.001) and delta cAMP/IS (r = 0.922, p less than 0.001). These results support the hypothesis that the impairment of beta-adrenoceptor sensitivity observed in human hypertension is associated with a beta-adrenoceptor overstimulation due to chronically elevated adrenergic tone.


This article has been cited by other articles:


Home page
HypertensionHome page
Y. Iwashima, T. Katsuya, K. Ishikawa, N. Ouchi, M. Ohishi, K. Sugimoto, Y. Fu, M. Motone, K. Yamamoto, A. Matsuo, et al.
Hypoadiponectinemia Is an Independent Risk Factor for Hypertension
Hypertension, June 1, 2004; 43(6): 1318 - 1323.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Julius, M. Valentini, and P. Palatini
Overweight and Hypertension : A 2-Way Street?
Hypertension, March 1, 2000; 35(3): 807 - 813.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Palatini, O. Vriz, S. Nesbitt, J. Amerena, S. Majahalme, M. Valentini, and S. Julius
Parental Hyperdynamic Circulation Predicts Insulin Resistance in Offspring : The Tecumseh Offspring Study
Hypertension, March 1, 1999; 33(3): 769 - 774.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Elhendy, R. T. van Domburg, J. R. T. C. Roelandt, M. L. Geleijnse, M. M. Ibrahim, and P. M. Fioretti
Safety and Feasibility of Dobutamine-Atropine Stress Testing in Hypertensive Patients
Hypertension, June 1, 1997; 29(6): 1232 - 1239.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. Sherwood, A. L. Hinderliter, and K. C. Light
Physiological Determinants of Hyperreactivity to Stress in Borderline Hypertension
Hypertension, March 1, 1995; 25(3): 384 - 390.
[Abstract] [Full Text]